Novo Nordisk defends next-gen obesity drug CagriSema, gives details of new trial
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
PM Modi on India’s growing obesity problem: Akshay Kumar and experts weigh in
To tackle obesity, experts recommend healthy oils, proper diet, adequate sleep, and exercise. PM Modi's address highlight the ...
Tech mogul Bryan Johnson connects America’s obesity epidemic to India’s air pollution crisis. Does he have a point?
Tech millionaire Bryan Johnson abruptly ended a podcast in India due to severe air pollution. He later talked about it in his ...
Novartis Sets High Bar in Pursuit of Obesity Deals, CEO Says
The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...
News Medical2d
Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs
Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...
China has free health care and lower rates of obesity. Here’s how the life expectancy compares to the U.S.
Still, the adult obesity rate in the U.S. is 42.4% vs. 14% in China—though it’s expected to rise along with interest in fast ...